The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk
Ovarian cancer (OC) is the most lethal gynecological cancer worldwide. DNA damage plays an important role in cancer development, and the proteins encoded by XRCC1 and ERCC2 are important components of the DNA repair system. This study aimed to examine the relationship between the rs25487 XRCC1 and...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2024-12-01
|
| Series: | Biomolecules & Biomedicine |
| Subjects: | |
| Online Access: | https://www.bjbms.org/ojs/index.php/bjbms/article/view/11314 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846115275960745984 |
|---|---|
| author | Tatiana Zavarykina Maria Kapralova Polina Lomskova Aleksandra Asaturova Grigory Khabas Lyailya Kayumova Dmitry Khodyrev Irina Pronina Maya Sannikova Svetlana Khokhlova |
| author_facet | Tatiana Zavarykina Maria Kapralova Polina Lomskova Aleksandra Asaturova Grigory Khabas Lyailya Kayumova Dmitry Khodyrev Irina Pronina Maya Sannikova Svetlana Khokhlova |
| author_sort | Tatiana Zavarykina |
| collection | DOAJ |
| description |
Ovarian cancer (OC) is the most lethal gynecological cancer worldwide. DNA damage plays an important role in cancer development, and the proteins encoded by XRCC1 and ERCC2 are important components of the DNA repair system. This study aimed to examine the relationship between the rs25487 XRCC1 and rs13181 ERCC2 polymorphisms and the risk of OC development in women from the Moscow region. DNA was isolated from the blood of 129 healthy donors and tissues and blood samples from 125 patients with OC and studied using real-time PCR. An increase in odds ratios (OR) was obtained for OC tissue and blood for both T (OR = 1.46, 95% confidence interval [CI] = 1.22–1.76, P = 0.00005), and for T/T of rs25487 XRCC1. The most significant OR values were found for the T/T genotype using the codominant model (OR = 2.11, 95% CI = 1.44–3.07, P = 0.00006) and dominant model (OR = 3.13, 95% CI = 1.44–6.79, P = 0.0025) for the pooled blood and tissue groups. For rs13181 ERCC2, differences were observed for the T/G genotype in OC tissues (OR = 0.69, 95% CI = 0.51–0.92, P = 0.011) in the codominant model. In this study, the association of allele T and genotypes of rs25487 XRCC1 and T/G of rs13181 ERCC2 with OC was shown. Our results indicate that these polymorphisms may be involved in the pathogenesis of OC and are promising for further studies on therapeutic applications in OC.
|
| format | Article |
| id | doaj-art-e9bb03f32acd46edbd8df9ead19ef1dd |
| institution | Kabale University |
| issn | 2831-0896 2831-090X |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina |
| record_format | Article |
| series | Biomolecules & Biomedicine |
| spelling | doaj-art-e9bb03f32acd46edbd8df9ead19ef1dd2024-12-19T16:30:57ZengAssociation of Basic Medical Sciences of Federation of Bosnia and HerzegovinaBiomolecules & Biomedicine2831-08962831-090X2024-12-0110.17305/bb.2024.11314The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer riskTatiana Zavarykina0https://orcid.org/0000-0002-5993-6351Maria Kapralova1https://orcid.org/0000-0003-3010-3994Polina Lomskova2Aleksandra Asaturova3https://orcid.org/0000-0001-8739-5209Grigory Khabas4Lyailya Kayumova5https://orcid.org/0000-0003-0301-737XDmitry Khodyrev6Irina Pronina7https://orcid.org/0000-0002-0423-7801Maya Sannikova8Svetlana Khokhlova9https://orcid.org/0000-0002-4597-172XN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, Moscow, Russia; "B.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology", Ministry of Health of the Russian Federation, Moscow, RussiaN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, Moscow, RussiaN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, Moscow, Russia"B.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology", Ministry of Health of the Russian Federation, Moscow, Russia"B.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology", Ministry of Health of the Russian Federation, Moscow, RussiaSechenov First Moscow State Medical University (Sechenov University), Moscow, RussiaFederal Scientific and Clinical Center of Specialized Types of Medical Care and Medical Technologies, Federal Medical and Biological Agency of the Russian Federation, Moscow, RussiaN.M. Emanuel Institute of Biochemical Physics of Russian Academy of Sciences, Moscow, Russia; Institute of General Pathology and Pathophysiology, Moscow, Russia"B.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology", Ministry of Health of the Russian Federation, Moscow, Russia; Yaroslav-the-Wise Novgorod State University, Novgorod, Russia"B.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology", Ministry of Health of the Russian Federation, Moscow, Russia Ovarian cancer (OC) is the most lethal gynecological cancer worldwide. DNA damage plays an important role in cancer development, and the proteins encoded by XRCC1 and ERCC2 are important components of the DNA repair system. This study aimed to examine the relationship between the rs25487 XRCC1 and rs13181 ERCC2 polymorphisms and the risk of OC development in women from the Moscow region. DNA was isolated from the blood of 129 healthy donors and tissues and blood samples from 125 patients with OC and studied using real-time PCR. An increase in odds ratios (OR) was obtained for OC tissue and blood for both T (OR = 1.46, 95% confidence interval [CI] = 1.22–1.76, P = 0.00005), and for T/T of rs25487 XRCC1. The most significant OR values were found for the T/T genotype using the codominant model (OR = 2.11, 95% CI = 1.44–3.07, P = 0.00006) and dominant model (OR = 3.13, 95% CI = 1.44–6.79, P = 0.0025) for the pooled blood and tissue groups. For rs13181 ERCC2, differences were observed for the T/G genotype in OC tissues (OR = 0.69, 95% CI = 0.51–0.92, P = 0.011) in the codominant model. In this study, the association of allele T and genotypes of rs25487 XRCC1 and T/G of rs13181 ERCC2 with OC was shown. Our results indicate that these polymorphisms may be involved in the pathogenesis of OC and are promising for further studies on therapeutic applications in OC. https://www.bjbms.org/ojs/index.php/bjbms/article/view/11314ovarian cancerOCDNA repairXRCC1 geneERCC2 genepolymorphism |
| spellingShingle | Tatiana Zavarykina Maria Kapralova Polina Lomskova Aleksandra Asaturova Grigory Khabas Lyailya Kayumova Dmitry Khodyrev Irina Pronina Maya Sannikova Svetlana Khokhlova The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk Biomolecules & Biomedicine ovarian cancer OC DNA repair XRCC1 gene ERCC2 gene polymorphism |
| title | The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk |
| title_full | The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk |
| title_fullStr | The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk |
| title_full_unstemmed | The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk |
| title_short | The association of rs25487 of the XRCC1 gene and rs13181 of the ERCC2 gene polymorphisms with the ovarian cancer risk |
| title_sort | association of rs25487 of the xrcc1 gene and rs13181 of the ercc2 gene polymorphisms with the ovarian cancer risk |
| topic | ovarian cancer OC DNA repair XRCC1 gene ERCC2 gene polymorphism |
| url | https://www.bjbms.org/ojs/index.php/bjbms/article/view/11314 |
| work_keys_str_mv | AT tatianazavarykina theassociationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT mariakapralova theassociationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT polinalomskova theassociationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT aleksandraasaturova theassociationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT grigorykhabas theassociationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT lyailyakayumova theassociationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT dmitrykhodyrev theassociationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT irinapronina theassociationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT mayasannikova theassociationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT svetlanakhokhlova theassociationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT tatianazavarykina associationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT mariakapralova associationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT polinalomskova associationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT aleksandraasaturova associationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT grigorykhabas associationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT lyailyakayumova associationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT dmitrykhodyrev associationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT irinapronina associationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT mayasannikova associationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk AT svetlanakhokhlova associationofrs25487ofthexrcc1geneandrs13181oftheercc2genepolymorphismswiththeovariancancerrisk |